David Soergel, M.D.

David Soergel, M.D.

Executive Vice President and Chief Medical OfficeratMadrigal Pharmaceuticals· In the 2025 proxy

Pay in FY2025Madrigal Pharmaceuticals stock +88.7% the same year

David Soergel, M.D. was paid $9.2M in FY2025 (Dec). Madrigal Pharmaceuticals stock rose 88.7% that year.

Pay$100 in the stock at the end of FY24 → $189
Pay is from the Summary Compensation Table of each Madrigal Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Madrigal PharmaceuticalsPublic company · 1 yr
    • Executive Vice President and Chief Medical Officer2025 – Present · 1 yrStock in role +38%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?